McClain Value Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-9,154
Closed -$297K 29
2017
Q1
$297K Sell
9,154
-1,179
-11% -$37.2K 0.38% 28
2016
Q4
$318K Sell
10,333
-41,200
-80% -$1.26M 0.39% 28
2016
Q3
$1.66M Buy
51,533
+1,179
+2% +$39.4K 1.33% 26
2016
Q2
$1.68M Sell
50,354
-132,672
-72% -$4.23M 1.43% 25
2016
Q1
$5.15M Sell
183,026
-249,771
-58% -$7.13M 4.07% 14
2015
Q4
$13.3M Sell
432,797
-45,055
-9% -$1.42M 4.75% 10
2015
Q3
$14.2M Sell
477,852
-24,964
-5% -$800K 4.5% 15
2015
Q2
$16M Sell
502,816
-7,281
-1% -$237K 3.99% 15
2015
Q1
$16.8M Sell
510,097
-353,707
-41% -$11.2M 3.99% 12
2014
Q4
$25.5M Buy
863,804
+48,183
+6% +$1.38M 5.26% 7
2014
Q3
$22.9M Buy
815,621
+3,475
+0.4% +$97.5K 4.36% 12
2014
Q2
$22.9M Buy
812,146
+29,075
+4% +$829K 3.96% 14
2014
Q1
$23.9M Buy
783,071
+16,256
+2% +$485K 4.52% 9
2013
Q4
$22.3M Sell
766,815
-40,398
-5% -$1.18M 4.39% 9
2013
Q3
$22M Buy
807,213
+82,943
+11% +$2.26M 4.65% 13
2013
Q2
$19.2M Buy
+724,270
New +$20M 4.13% 11

Other funds holding PFE

McClain Value Management's PFE Position: Q2 2017 in Review

McClain Value Management sold out of Pfizer (PFE) in Q2 2017, closing a stake of 9,154 shares — an estimated $297K sold.

McClain Value Management first reported a position in PFE in Q2 2013 and held it in 16 quarters. The position peaked at $25.5M in Q4 2014. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

  • McClain Value Management reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
  • McClain Value Management sold 9,154 Pfizer shares in Q2 2017, an estimated $297K.
  • McClain Value Management first reported a position in Pfizer in Q2 2013 and held it in 16 quarters.
  • McClain Value Management's Pfizer position peaked at $25.5M in Q4 2014.
  • 2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on McClain Value Management's 13F filing for Q2 2017, filed 14 Aug 2017.